The Hip Preservation Surgery Expectations Survey (HPSES) developed by Mancuso et al. is an attempt to better predict outcome and/or discriminate between patients who are candidates for hip preservation surgery. The authors have ensured that patient input was paramount in the development of the survey. There are limitations to this study. However, with further prospective evaluation, this survey may provide important evaluative and discriminative information to improve patient selection.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.arthro.2017.01.019 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Treatment with a superoxide dismutase mimetic for joint preservation during 35 and 75 days in orbit aboard the international space station, and after 120 days recovery on Earth.
Life Sci Space Res (Amst)
February 2025
Department of Radiation Oncology, Wake Forest University School of Medicine. Winston-Salem, NC, USA. Electronic address:
Reduced weight-bearing during spaceflight has been associated with musculoskeletal degradation that risks astronaut health and performance in transit and upon reaching deep space destinations. Previous rodent experiments aboard the international space station (ISS) have identified that the spaceflight-induced molecular arthritic phenotype was characterized with an increase in oxidative stress. This study evaluated if treatment with a superoxide dismutase (SOD) mimetic on orbit could prevent spaceflight-induced damage to the knee and hip articular cartilage, and the menisci in rodents.
View Article and Find Full Text PDFIntravenous Tranexamic Acid Does Not Improve Visual Field Clarity During Hip Arthroscopy: A Double-Blind, Randomized, Placebo-Controlled Trial.
Arthroscopy
January 2025
Department of Orthopaedic Surgery, Hospital for Special Surgery, New York, NY, USA.
Purpose: To determine the effectiveness of administering intravenous (IV) tranexamic acid (TXA) on altering visual field clarity (VFC) during arthroscopic hip preservation surgery for patients with femoroacetabular impingement syndrome (FAIS).
Methods: This randomized, double-blind, parallel-design trial was conducted over a seven-month period between October 2023 and May 2024 at a single tertiary musculoskeletal hospital. Inclusion criteria included consecutive patients that were diagnosed with FAIS through clinical history, physical exam and advanced imaging and indicated for hip arthroscopy after having failed conservative management.
Fibrous dysplasia (FD) is a benign tumor condition in which normal bone is replaced by structurally deficient fibrous lamellar bone. It represents approximately 5-7% of benign bone tumors and occurs in two presentations: monostotic, which is the most common, and polyostotic. The proximal femur is one of the most common locations for benign tumors, including FD.
View Article and Find Full Text PDFSHORT TERM COMPARISON OF CLINIC RADIOGRAPHIC RESULTS OF TOTAL HIP REPLACEMENT WITH SHORT FEMORAL STEM IN OBESE AND NON-OBESE YOUNG PATIENTS. SINGLE CENTER PROSPECTIVE PILOT STUDY.
Georgian Med News
November 2024
Servicio de Ortopedia y Traumatología, Hospital de San Rafael, Hospitales Pascual, Cadiz, España.
Background: Total hip arthroplasty (THA) is a highly successful orthopedic procedure increasingly performed on younger, obese patients due to its ability to improve functional outcomes and quality of life. However, obesity presents challenges related to implant selection and long-term outcomes, particularly with the use of short femoral stems. While short stems offer benefits such as bone preservation and reduced stress shielding, their reliability in obese patients remains underreported.
View Article and Find Full Text PDFBreaking Barriers: Addressing Gender Disparities in Hip Resurfacing Surgery Access in the United States.
Arch Bone Jt Surg
January 2024
Orthopedic Research Center, Department of Orthopedic Surgery, Mashhad University of Medical sciences, Mashhad, Iran.
Second-generation large-diameter head hip resurfacing (HR) arthroplasty has gained popularity in terms of its potential for minimal wear and the preservation of proximal femoral bone stock. HR faces challenges, such as increased hip fracture rates and adverse reactions to metal detritus, despite the fact that over one million metal-on-metal (MoM) arthroplasties have been performed globally. FDA issued warnings in 2011 and 2016 regarding higher failure rates in women and categorized MoM implants as high-risk, influencing U.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!